Eko’s software and smart digital stethoscope combined with Mayo clinic and aims to help physicians with earlier detection of life-threatening conditions.
Eko, creators of a heart and lung monitoring platform that combines non-invasive cardiac sensors with machine learning, has announced a collaboration with Mayo Clinic to develop a data-driven technology – using machine learning and a smart digital stethoscope – to help physicians detect patients with potentially dangerous heart diseases that may otherwise be missed. Mayo Clinic is a nonprofit organization committed to clinical practice, education, and research, providing expert, whole-person care to everyone who needs healing.
Eko and Mayo Clinic will work together to develop and commercialize a machine learning-based algorithm that screens patients for the presence of a low ejection fraction – a weak heart pump. Once identified, evidence-based treatments are available, that prolongs life and reduces the risk of symptoms. Eko aims to gain FDA approval for the technology after running clinical studies with Mayo Clinic to demonstrate the safety and effectiveness of the algorithms for in-clinic screening.
Advanced Lifesaving technology
Earlier, ejection fraction is measured by imaging techniques such as echocardiography, which is a powerful but expensive and time-consuming test that is less accessible to most people in North America and around the world than a doctor with a stethoscope. The technology leverages the Mayo Clinic’s vast cardiovascular database and their expertise in medical AI and heart disease screening and combines it with Eko’s cardiac monitoring platform. With this algorithm, Eko can help screen patients in seconds in the doctor’s office. Any health care provider can use the Eko tool, it may detect heart function abnormalities earlier and in patients who might not otherwise be screened for heart disease.
Eko CEO, Connor Landgraf, said, “It’s a privilege to collaborate with Mayo Clinic on this technology that can assist physicians with their patients’ cardiovascular care. By co-developing this technology, we can combine the knowledge of millions of ECGs and healthcare screenings to get an almost instantaneous snapshot of a patient’s heart.”
